Since 2017, The Biocodex Microbiota Foundation rewards national research initiatives which aim to understand the interaction between microbiota and different pathologies. By promoting scientists from around the world at a key moment in their career, the grant seeks to motivate researchers to continue to explore the world of gut microbiota.
The annual call for proposals is carried out in countries where Biocodex has a subsidiary presence. An independent local scientific committee – made up of individuals recognized for their expertise in the microbiota field – gathers all proposals and selects the winning project to be granted.
Biocodex Microbiota Foundation in collaboration with Biocodex Microbiota Institute put national winners in the spotlight through testimonies and interviews!
Since 2017, The Biocodex Microbiota Foundation rewards national research initiatives which aim to understand the interaction between microbiota and different pathologies. By promoting scientists from around the world at a key moment in their career, the grant seeks to motivate researchers.
Granted projects
2019
Etude de la composition du microbiote associé à la muqueuse gastrique chez les patients atteints de lymphome gastrique du MALT - Caractérisation d’une dysbiose spécifique chez les patients atteints de lymphome gastrique du MALT Helicobacter pylori négatif
Role of mucin-type O-glycans in regulating commensal vs. pathologic functions of Prevotella species in IBD
Ghent University trial in Parkinson’s with faecal transplantation
2018
R-HTN-associated gut dysbiosis alters gut-brain axis and antihypertensive drugs’ efficacy
Intestinal microbiota as a target for the treatment of non-alcoholic fatty liver disease
Метагеномный анализ изменений микробиома кишечника у больных желчнокаменной болезнью до и после холецистэктомии
Commensal bacteria in the attenuation of intestinal inflammation - molecular mechanisms of functionality of isolated novel strains
Gut microbiota in relation to early growth and development of childhood obesity
Etude de la mise en place du microbiiote intestinal chez les nouveau-nés prématurés exposés à une antibiothérapie et hospitalisés au service de néonatologie